Novo Holdings A/S’s Alder Biopharmaceuticals ALDR Stock Holding History

Novo Holdings A/S’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-1,951,183	Closed	-$103M	–	21
2015 Q2	$103M	Sell	1,951,183 -1,250,000	-39%	-$45.5M	7.43%	6
2015 Q1	$92.4M	Hold	3,201,183	–	–	7.86%	6
2014 Q4	$93.1M	Hold	3,201,183	–	–	7.53%	5
2014 Q3	$40.6M	Hold	3,201,183	–	–	3.96%	6
2014 Q2	$64.2M	Buy	+3,201,183	New	+$45.1M	6.35%	5

Other funds holding ALDR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Novo Holdings A/S's ALDR Position: Q3 2015 in Review

Novo Holdings A/S sold out of Alder Biopharmaceuticals (ALDR) in Q3 2015, closing a stake of 1,951,183 shares — an estimated $103M sold.

Novo Holdings A/S first reported a position in ALDR in Q2 2014 and held it in 5 quarters. The position peaked at $103M in Q2 2015. 140 funds tracked by Wall St. Rank hold ALDR as of Q3 2015.

Novo Holdings A/S reported no remaining Alder Biopharmaceuticals position as of Q3 2015 after selling out during the quarter.
Novo Holdings A/S sold 1,951,183 Alder Biopharmaceuticals shares in Q3 2015, an estimated $103M.
Novo Holdings A/S first reported a position in Alder Biopharmaceuticals in Q2 2014 and held it in 5 quarters.
Novo Holdings A/S's Alder Biopharmaceuticals position peaked at $103M in Q2 2015.
140 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q3 2015.

Based on Novo Holdings A/S's 13F filing for Q3 2015, filed 16 Nov 2015.